Skip to content
lifestyle.independent.mk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Tris Pharma, Inc.
Tris Pharma Introduces New 30-Count Bottle Size for QuilliChew ER® (methylphenidate HCl) Extended-Release Chewable Tablets for Attention Deficit Hyperactivity Disorder (ADHD)
September 14, 2026
Tris Pharma to Showcase ADHD Leadership and Commitment to Individualized Care at Fall 2026 Medical Conferences
September 1, 2026
Tris Pharma Expands Support for People Living with ADHD Through New Partnerships with Calm Health and ADHD Central
August 12, 2026
Tris Pharma Appoints Jim Potenziano, Ph.D. as Chief Science and Development Officer
May 22, 2026
Tris Pharma to Showcase Encore Phase 3 Data Supporting Continued Progress in Acute Pain Treatment at ASRA 2026 Meeting in Phoenix
April 8, 2026